These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20800406)

  • 21. Determination of active ingredient within pharmaceutical preparations using flow injection mass spectrometry.
    Wade N; Miller K
    J Pharm Biomed Anal; 2005 Apr; 37(4):669-78. PubMed ID: 15797787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of inorganic pharmaceutical counterions using hydrophilic interaction chromatography coupled with a Corona CAD detector.
    Huang Z; Richards MA; Zha Y; Francis R; Lozano R; Ruan J
    J Pharm Biomed Anal; 2009 Dec; 50(5):809-14. PubMed ID: 19616396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry.
    Harvey DJ
    Expert Rev Proteomics; 2005 Jan; 2(1):87-101. PubMed ID: 15966855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the oligosaccharide composition of commercial follicle stimulating hormone preparations.
    Lombardi A; Andreozzi C; Pavone V; Triglione V; Angiolini L; Caccia P
    Electrophoresis; 2013 Aug; 34(16):2394-406. PubMed ID: 23775770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells.
    Gawlitzek M; Valley U; Wagner R
    Biotechnol Bioeng; 1998 Mar; 57(5):518-28. PubMed ID: 10099230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography/tandem mass spectrometric analysis of drugs in biological matrix.
    Yan Z; Maher N; Torres R; Cotto C; Hastings B; Dasgupta M; Hyman R; Huebert N; Caldwell GW
    Rapid Commun Mass Spectrom; 2008 Jul; 22(13):2021-8. PubMed ID: 18512848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of N-glycans of recombinant human thyrotropin using mass spectrometry.
    Morelle W; Donadio S; Ronin C; Michalski JC
    Rapid Commun Mass Spectrom; 2006; 20(3):331-45. PubMed ID: 16372382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical characterization of an orally-delivered peptide pharmaceutical product.
    Kelley WP; Chen S; Floyd PD; Hu P; Kapsi SG; Kord AS; Sun M; Vogt FG
    Anal Chem; 2012 May; 84(10):4357-72. PubMed ID: 22497462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single drop microextraction as a concentrating probe for rapid screening of low molecular weight drugs from human urine in atmospheric-pressure matrix-assisted laser desorption/ionization mass spectrometry.
    Shrivas K; Wu HF
    Rapid Commun Mass Spectrom; 2007; 21(18):3103-8. PubMed ID: 17708597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
    Jemal M; Ouyang Z; Powell ML
    Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 32. Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT.
    Quaak SG; Nuijen B; Haanen JB; Beijnen JH
    J Pharm Biomed Anal; 2009 Feb; 49(2):282-8. PubMed ID: 19111423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analytical aspects of biosimilarity issues of protein drugs.
    Kálmán-Szekeres Z; Olajos M; Ganzler K
    J Pharm Biomed Anal; 2012 Oct; 69():185-95. PubMed ID: 22633839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The sacred cow: the questionable role of assay methods in characterising the quality of bulk pharmaceuticals.
    Görög S
    J Pharm Biomed Anal; 2005 Jan; 36(5):931-7. PubMed ID: 15620516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis.
    Lingg N; Zhang P; Song Z; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1462-72. PubMed ID: 22829536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-linked oligosaccharide analysis of glycoprotein bands from isoelectric focusing gels.
    Zhou Q; Park SH; Boucher S; Higgins E; Lee K; Edmunds T
    Anal Biochem; 2004 Dec; 335(1):10-6. PubMed ID: 15519566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatographic profiling of fluorescent labelled N-glycans on glycoproteins.
    Yuen CT; Gee CK; Jones C
    Biomed Chromatogr; 2002 Jun; 16(4):247-54. PubMed ID: 11933024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass spectrometry for structural characterization of therapeutic antibodies.
    Zhang Z; Pan H; Chen X
    Mass Spectrom Rev; 2009; 28(1):147-76. PubMed ID: 18720354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of N-palmitoylated human growth hormone by in situ liquid-liquid extraction and MALDI tandem mass spectrometry.
    Sachon E; Nielsen PF; Jensen ON
    J Mass Spectrom; 2007 Jun; 42(6):724-34. PubMed ID: 17428000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.